Description

Mycobacteria appears to be more prevalent in the CF population, and the prevalence of sub-species of sputum mycobacteria found are changing. The symposium addresses CF mycobacterial lung disease versus colonization, antibiotic treatment and duration of treatment. The issue of whether or not to proceed with lung transplantation in CF patients infected with mycobacteria is discussed. The molecular identification of various sub-species of mycobacteria and epidemiological implications is addressed.

• Summarize antibiotic susceptibility testing and monitoring treatment response of mycobacterial disease.
• Evaluate if patients with M. abscessus should undergo lung transplantation.
• Interpret mycobacteria strain genotyping.

Chair(s):

• Stacey L. Martiniano, M.D., Assistant Professor
• Moira Aitken, M.D., Director, Adult CF Clinic; Professor, University of Washington

Speaker(s):

• Jerry A. Nick, M.D., Director Adult CF Program
• Kenneth Olivier, M.D., M.P.H., Senior Clinician and Branch Chief
• Charles Haworth, M.D.
• Peadar Noone, M.D.